We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

79 hedge funds and large institutions have $236M invested in Minerva Neurosciences in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

18% more capital invested

Capital invested by funds: $200M → $236M (+$35.9M)

0.07% more ownership

Funds ownership: 9.56% → 9.63% (+0.07%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 84 → 79 (-5)

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Holders
79
Holders Change
-5
Holders Change %
-5.95%
% of All Funds
1.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
33
Reduced
21
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GC
GMT Capital
Georgia
+$7.49M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$669K
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$580K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$558K
5
Renaissance Technologies
Renaissance Technologies
New York
+$540K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.47M
2
HCMT
Highland Capital Management (Texas)
Texas
-$1.32M
3
Morgan Stanley
Morgan Stanley
New York
-$1.11M
4
SFM
Sphera Funds Management
Israel
-$1.05M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$931K
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$59.2M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$21.8M -$249K -4,138 -1%
BlackRock
3
BlackRock
New York
$18.8M -$474K -7,890 -3%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$13.2M +$558K +9,285 +5%
Vanguard Group
5
Vanguard Group
Pennsylvania
$13M +$377K +6,266 +3%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$12.4M +$580K +9,650 +5%
Franklin Resources
7
Franklin Resources
California
$9.44M – – –
GC
8
GMT Capital
Georgia
$7.83M +$7.49M +124,589 New
Millennium Management
9
Millennium Management
New York
$7.25M -$2.47M -41,144 -26%
IVAV
10
Index Venture Associates V
Jersey
$7.04M – – –
HCMT
11
Highland Capital Management (Texas)
Texas
$6.77M -$1.32M -21,938 -17%
SFM
12
Sphera Funds Management
Israel
$5.05M -$1.05M -17,500 -18%
Wellington Management Group
13
Wellington Management Group
Massachusetts
$4.82M – – –
CAM
14
Cormorant Asset Management
Massachusetts
$4.78M – – –
Renaissance Technologies
15
Renaissance Technologies
New York
$4.12M +$540K +8,988 +16%
State Street
16
State Street
Massachusetts
$3.96M +$61.4K +1,022 +2%
NLVP
17
New Leaf Venture Partners
New York
$3.33M – – –
Geode Capital Management
18
Geode Capital Management
Massachusetts
$2.99M +$170K +2,835 +6%
Northern Trust
19
Northern Trust
Illinois
$2.97M +$114K +1,905 +4%
JP Morgan Chase
20
JP Morgan Chase
New York
$2.75M +$392K +6,521 +18%
Handelsbanken Fonder
21
Handelsbanken Fonder
Sweden
$2M +$376K +6,250 +24%
TCIM
22
TIAA CREF Investment Management
New York
$1.88M +$67.6K +1,124 +4%
AL
23
AJO LP
Pennsylvania
$1.49M +$271K +4,503 +23%
MCM
24
Moore Capital Management
New York
$1.18M – – –
MWNA
25
Marshall Wace North America
New York
$1.08M -$625K -10,393 -38%
1
2 3 4

NERV Hedge Fund Activity: Q1 2019 in Review

79 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2019, worth a combined $236M — up 18% from $200M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of NERV and 4 opened new positions — a net loss of 5 holders — while 21 trimmed existing stakes and 33 added.

The largest buyer was GMT Capital, opening a new position worth an estimated $7.49M. The largest seller was Millennium Management, cutting an estimated $2.47M.

  • 79 institutional investors held Minerva Neurosciences (NERV) as of Q1 2019, down from 84 in Q4 2018.
  • Funds reported $236M of Minerva Neurosciences stock for Q1 2019, up 18% quarter-over-quarter.
  • 4 funds opened new Minerva Neurosciences positions in Q1 2019 and 9 closed out, a net change of -5 holders.
  • The largest Minerva Neurosciences buyer in Q1 2019 was GMT Capital, an estimated $7.49M added.
  • The largest Minerva Neurosciences seller in Q1 2019 was Millennium Management, an estimated $2.47M sold.

Based on aggregated 13F filings for Q1 2019.